| Q84102440 | 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: symbionts and immunopathology in chronic diseases: insights from evolution |
| Q35952148 | A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model |
| Q55403680 | A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass. |
| Q39322941 | A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma |
| Q42589659 | Advances in diagnosis and treatment of cholangiocarcinomas. |
| Q83481443 | An evolutionary perspective on parasitism as a cause of cancer |
| Q38148476 | An update on liver surgery for cholangiocarcinoma. |
| Q39184202 | Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model |
| Q42293542 | Approach of the patient with a liver mass |
| Q37246194 | Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma |
| Q40873283 | Aspirin use and the risk of cholangiocarcinoma |
| Q57485810 | Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis |
| Q24656650 | Association between hepatitis B virus and pancreatic cancer |
| Q64069091 | Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand |
| Q36194244 | Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study |
| Q91599654 | Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging |
| Q37131718 | BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype |
| Q43294211 | Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases |
| Q57610194 | Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis |
| Q33646525 | CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis |
| Q37860916 | Cholangiocarcinoma--controversies and challenges |
| Q36900063 | Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment |
| Q34034208 | Cholangiocarcinoma: lessons from Thailand |
| Q37582417 | Clinical analysis of cholangiocarcinoma patients receiving adjuvant radiotherapy |
| Q34614931 | Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma |
| Q36614705 | Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma |
| Q35176484 | Combined hepatocellular cholangiocarcinomas; analysis of a large database |
| Q35766425 | Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma |
| Q36243908 | Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis |
| Q89525165 | Diagnosis efficacy of CEUS for hepatic inflammatory lesions |
| Q57149171 | EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3 |
| Q89971071 | Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma |
| Q31046234 | Endoscopic management of hilar cholangiocarcinoma |
| Q39147308 | Epidemiology and Risk Factors of Cholangiocarcinoma |
| Q57139999 | Epidemiology and surgical management of intrahepatic cholangiocarcinoma |
| Q28293076 | Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma |
| Q33672901 | Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients. |
| Q45172696 | Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissues |
| Q36966040 | Genetic factors in the pathogenesis of cholangiocarcinoma |
| Q35249982 | Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States |
| Q30240220 | Global epidemiology and burden of HCV infection and HCV-related disease |
| Q40625065 | Healthcare utilization and costs associated with cholangiocarcinoma |
| Q54261265 | Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism. |
| Q33626806 | Hepatitis B virus infection and intrahepatic cholangiocarcinoma |
| Q28076535 | Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma |
| Q26998595 | Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies |
| Q31073665 | Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis |
| Q44188218 | High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases. |
| Q55130824 | Imagiological Diagnosis of Gastrointestinal Diseases - Diagnostic Criteria of Hepatocellular Carcinoma. |
| Q36009443 | Incidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study. |
| Q39763484 | Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study |
| Q34398255 | Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors |
| Q33785906 | Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center |
| Q58021493 | Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound |
| Q64053285 | Is exposure to tobacco associated with extrahepatic cholangiocarcinoma epidemics? A retrospective proportional mortality study in China |
| Q92786342 | Klatskin Tumor: A Population-Based Study of Incidence and Survival |
| Q38129312 | Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention |
| Q34874988 | Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study |
| Q64887814 | Metformin Induces Apoptosis and Inhibits Proliferation through the AMP-Activated Protein Kinase and Insulin-like Growth Factor 1 Receptor Pathways in the Bile Duct Cancer Cells. |
| Q50050635 | New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin. |
| Q37621790 | New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma |
| Q34656747 | Pathogenesis, diagnosis, and management of cholangiocarcinoma |
| Q35645739 | Perioperative Management of Hilar Cholangiocarcinoma |
| Q35868937 | Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. |
| Q44495220 | Primary liver cancer incidence among American Indians and Alaska Natives, US, 1999-2004. |
| Q37174653 | Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index |
| Q94527003 | Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection |
| Q48501525 | Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea |
| Q64070590 | Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand |
| Q35074664 | Risk factors for cholangiocarcinoma |
| Q34207893 | Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study |
| Q34186338 | Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates |
| Q46192546 | Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare. |
| Q34486878 | Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus |
| Q36589096 | Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk |
| Q37286554 | Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans |
| Q36771685 | Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification |
| Q47141943 | Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis |
| Q92287057 | Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies |
| Q56243454 | Smoking, alcohol consumption, and risks for biliary tract cancer and intrahepatic bile duct cancer |
| Q37408907 | Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis |
| Q100503932 | Spatial analysis of hepatobiliary abnormalities in a population at high-risk of cholangiocarcinoma in Thailand |
| Q37155579 | Staging of extrahepatic cholangiocarcinoma |
| Q41708799 | Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma |
| Q37080976 | The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. |
| Q38552233 | The risk factors and diagnosis of cholangiocarcinoma |
| Q52665718 | Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. |
| Q81787067 | Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes |
| Q37225736 | Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma |